• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人血清细小病毒作为镰状细胞病再生障碍危象的病因

Human serum parvovirus as the cause of aplastic crisis in sickle cell disease.

作者信息

Kelleher J F, Luban N L, Cohen B J, Mortimer P P

出版信息

Am J Dis Child. 1984 Apr;138(4):401-3. doi: 10.1001/archpedi.1984.02140420067020.

DOI:10.1001/archpedi.1984.02140420067020
PMID:6322575
Abstract

An infectious agent has long been suspected as the cause of aplastic crisis in sickle cell disease, but no specific organism has been implicated. We studied six children with sickle cell disease in whom an aplastic crisis developed, looking for evidence of parvoviruslike virus (SPLV) infection using a new radioimmunoassay. All six patients had conclusive evidence of acute infection with SPLV. We postulated that SPLV is the predominant cause of aplastic crises in patients with hemolytic anemia.

摘要

长期以来,人们一直怀疑感染因子是镰状细胞病再生障碍危象的病因,但尚未明确具体是哪种微生物。我们研究了6例发生再生障碍危象的镰状细胞病患儿,采用一种新的放射免疫测定法寻找细小病毒样病毒(SPLV)感染的证据。所有6例患者均有SPLV急性感染的确凿证据。我们推测SPLV是溶血性贫血患者再生障碍危象的主要病因。

相似文献

1
Human serum parvovirus as the cause of aplastic crisis in sickle cell disease.人血清细小病毒作为镰状细胞病再生障碍危象的病因
Am J Dis Child. 1984 Apr;138(4):401-3. doi: 10.1001/archpedi.1984.02140420067020.
2
Infection with parvovirus-like virus and aplastic crisis in chronic hemolytic anemia.细小病毒样病毒感染与慢性溶血性贫血中的再生障碍危象
Ann Intern Med. 1983 Jun;98(6):930-2. doi: 10.7326/0003-4819-98-6-930.
3
Parvovirus associated aplastic crisis in homozygous sickle cell disease.纯合子镰状细胞病中的细小病毒相关再生障碍性危象
Arch Dis Child. 1987 Jun;62(6):585-8. doi: 10.1136/adc.62.6.585.
4
Characterization of a virus that causes transient aplastic crisis.一种引发暂时性再生障碍性危象的病毒的特性分析。
J Clin Invest. 1984 Jan;73(1):224-30. doi: 10.1172/JCI111195.
5
The development and use of an antibody capture radioimmunoassay for specific IgM to a human parvovirus-like agent.一种针对人细小病毒样病原体特异性 IgM 的抗体捕获放射免疫测定法的开发与应用。
J Hyg (Lond). 1982 Apr;88(2):309-24. doi: 10.1017/s0022172400070169.
6
The role of parvovirus B19 in aplastic crisis and erythema infectiosum (fifth disease).细小病毒B19在再生障碍性危象和传染性红斑(第五病)中的作用。
J Infect Dis. 1986 Sep;154(3):383-93. doi: 10.1093/infdis/154.3.383.
7
Aplastic crisis in sickle cell disorders: bone marrow necrosis and human parvovirus infection.镰状细胞疾病中的再生障碍危象:骨髓坏死与人类细小病毒感染
Am J Med Sci. 1988 Mar;295(3):212-5. doi: 10.1097/00000441-198803000-00009.
8
Aplastic crisis due to extensive bone marrow necrosis and human parvovirus infection in sickle cell disease.
Am J Med. 1991 Nov;91(5):557-8. doi: 10.1016/0002-9343(91)90198-7.
9
Six cases of hereditary spherocytosis revealed by human parvovirus infection.6例由人细小病毒感染引发的遗传性球形红细胞增多症
Br J Haematol. 1986 Apr;62(4):653-8. doi: 10.1111/j.1365-2141.1986.tb04088.x.
10
Hypothesis: the aplastic crisis of hereditary spherocytosis is due to a single transmissible agent.假说:遗传性球形红细胞增多症的再生障碍危象是由单一可传播因子引起的。
J Clin Pathol. 1983 Apr;36(4):445-8. doi: 10.1136/jcp.36.4.445.

引用本文的文献

1
Immune Cell Profiles of Patients with Sickle Cell Disease during Parvovirus B19-Induced Transient Red Cell Aplasia.细小病毒B19诱导的短暂红细胞再生障碍期间镰状细胞病患者的免疫细胞谱
Vaccines (Basel). 2024 Aug 29;12(9):984. doi: 10.3390/vaccines12090984.
2
Hypothesis: Low Vitamin A and D Levels Worsen Clinical Outcomes When Children with Sickle Cell Disease Encounter Parvovirus B19.假说:当镰状细胞病患儿遭遇细小病毒 B19 时,低维生素 A 和 D 水平会使临床结果恶化。
Nutrients. 2022 Aug 19;14(16):3415. doi: 10.3390/nu14163415.
3
Novel Surrogate Neutralizing Assay Supports Parvovirus B19 Vaccine Development for Children with Sickle Cell Disease.
新型替代中和试验支持镰状细胞病患儿的B19型细小病毒疫苗研发。
Vaccines (Basel). 2021 Aug 4;9(8):860. doi: 10.3390/vaccines9080860.
4
Vaccine Design Informed by Virus-Induced Immunity.基于病毒诱导免疫的疫苗设计。
Viral Immunol. 2020 May;33(4):342-350. doi: 10.1089/vim.2019.0138. Epub 2020 May 5.
5
Saccharomyces cerevisiae-derived virus-like particle parvovirus B19 vaccine elicits binding and neutralizing antibodies in a mouse model for sickle cell disease.酿酒酵母衍生的病毒样颗粒细小病毒B19疫苗在镰状细胞病小鼠模型中引发结合抗体和中和抗体。
Vaccine. 2017 Jun 22;35(29):3615-3620. doi: 10.1016/j.vaccine.2017.05.022. Epub 2017 May 26.
6
Human Parvoviruses.人类细小病毒
Clin Microbiol Rev. 2017 Jan;30(1):43-113. doi: 10.1128/CMR.00040-16.
7
Original Research: Parvovirus B19 infection in children with sickle cell disease in the hydroxyurea era.原创研究:羟基脲时代镰状细胞病患儿的细小病毒B19感染
Exp Biol Med (Maywood). 2016 Apr;241(7):749-54. doi: 10.1177/1535370216636723. Epub 2016 Mar 2.
8
Pathogenesis of human parvovirus B19 in rheumatic disease.人类细小病毒B19在风湿性疾病中的发病机制。
Ann Rheum Dis. 2000 Sep;59(9):672-83. doi: 10.1136/ard.59.9.672.
9
Parvovirus B19 infection in pediatric transplant patients.小儿移植患者中的细小病毒B19感染
Transplantation. 1993 Oct;56(4):835-8. doi: 10.1097/00007890-199310000-00011.
10
Detection of antibodies and antigens of human parvovirus B19 by enzyme-linked immunosorbent assay.通过酶联免疫吸附测定法检测人细小病毒B19的抗体和抗原。
J Clin Microbiol. 1986 Oct;24(4):522-6. doi: 10.1128/jcm.24.4.522-526.1986.